Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 1 18Phase NA 13Phase 1/2 7Phase EARLY_PHASE1 4

Status

Completed 11Withdrawn 4Terminated 4Active not recruiting 4Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Turcot syndrome 1Skin Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Endometrial Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7Cyclophosphamide 6pembrolizumab 5Radiosurgery 5Nivolumab 4Fluorouracil 4Carboplatin 4Blood Specimen Collection 4Biopsy 4X-Rays 3Vincristine 3Surveys and Questionnaires 3Proflavine 3Positron-Emission Tomography 3Metformin 3Cisplatin 3Bevacizumab 3fludarabine phosphate 2durvalumab 2atezolizumab 2Varenicline 2Topotecan 2Taxes 2Specimen Handling 2Rituximab 2Radiotherapy 2Positron Emission Tomography Computed Tomography 2Oxaliplatin 2Leucovorin 2Letrozole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × Biopsy × Clear all
NCT04906382 2025-02-13

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
2 enrolled
GastrointestinalGynecologic

Turcot syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

NCT00736450 2023-10-24

Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

University of Nebraska

Phase EARLY_PHASE1 Terminated
37 enrolled 8 charts
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00651976 2018-10-15

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Terminated
213 enrolled
Breast

Breast Neoplasms

NCT00663910 2017-01-02

Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer

The Cleveland Clinic

Phase EARLY_PHASE1 Terminated
18 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡